ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian... von Herzog, Thomas J., Hays, John L., Barlin, Joyce N., Buscema, Joseph, Cloven, Noelle Gillette, Kong, Lynn R., Tyagi, Nidhi Kumar, Lanneau, Grainger, Long, Beverly J, Marsh, Robert L., Seward, Shelly Marie, Starks, David, Welch, Stephen, Moore, Kathleen N., Konstantinopoulos, Panagiotis A., Gilbert, Lucy, Monk, Bradley J., O'Malley, David M., Coleman, Robert L., Sehouli, Jalid

Volltext

Phase I/II study of niraparib plus pembrolizumab in patients with triple-negative breast cancer or recurrent ovarian cancer (KEYNOTE-162) von Konstantinopoulos, Panagiotis, Moore, Kathleen N., Sachdev, Jasgit C., Mita, Monica M., Vinayak, Shaveta, Seward, Shelly Marie, Karantza, Vassiliki, Aktan, Gursel, Ferguson, Andrew, Bobilev, Dmitri, Matulonis, Ursula A.

Volltext

Phase I study of anti-mesothelin antibody drug conjugate anetumab ravtansine (AR) von Blumenschein, George R., Hassan, Raffit, Moore, Kathleen N., Santin, Alessandro, Kindler, Hedy L., Nemunaitis, John J., Seward, Shelly Marie, Rajagopalan, Prabhu, Walter, Annette, Sarapa, Nenad, Bendell, Johanna C.

Volltext

Mirvetuximab soravtansine (IMGN853), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in platinum-resistant epithelial ovarian cancer (EOC) patients (pts): Ac... von Moore, Kathleen N., Matulonis, Ursula A., O'Malley, David M., Konner, Jason A., Martin, Lainie P., Perez, Raymond P., Bauer, Todd Michael, Gilbert, Lucy, Seward, Shelly Marie, Oza, Amit M., Ruiz-Soto, Rodrigo, Birrer, Michael J.

Volltext

IMGN853 (mirvetuximab soravtansine), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC): Single-agent activity in platinum-resistant epithelial ovarian cancer (E... von Moore, Kathleen N., Martin, Lainie P., Matulonis, Ursula A., Konner, Jason A., Seward, Shelly Marie, Bauer, Todd Michael, O'Malley, David M., Perez, Raymond P., Jeong, Woondong, Zhou, Yinghui, Kirby, Maurice William, Mohanavelu, Satishkumar, Ruiz-Soto, Rodrigo, Birrer, Michael J.

Volltext

Preliminary single agent activity of IMGN853, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in platinum-resistant epithelial ovarian cancer (EOC) patients... von Moore, Kathleen N., Martin, Lainie P., Seward, Shelly Marie, Bauer, Todd Michael, O'Malley, David M., Perez, Raymond P., Oza, Amit M., Jeong, Woondong, Kirby, Maurice William, Zhou, Yinghui, Michenzie, Mary F., Ponte, Joseph, Ruiz-Soto, Rodrigo, Birrer, Michael J.

Volltext

Phase 1 study of IMGN853, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC) in patients (Pts) with epithelial ovarian cancer (EOC) and other FRA-positive solid... von Borghaei, Hossein, O'Malley, David M., Seward, Shelly Marie, Bauer, Todd Michael, Perez, Raymond P., Oza, Amit M., Jeong, Woondong, Michenzie, Mary F., Kirby, Maurice William, Chandorkar, Gurudatt, Ruiz-Soto, Rodrigo, Birrer, Michael J., Moore, Kathleen N.

Volltext